Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura

Raval, Jay S.; Padmanabhan, Anand; Kremer Hovinga, Johanna Anna; Kiss, Joseph E. (2015). Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura. American journal of hematology, 90(1), E22-E22. Wiley-Liss 10.1002/ajh.23851

[img] Text
PubCrawler_01.10.15.tmp.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (108kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene)

UniBE Contributor:

Kremer Hovinga, Johanna Anna

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0361-8609

Publisher:

Wiley-Liss

Language:

English

Submitter:

Verena Zwahlen

Date Deposited:

07 Mar 2016 10:13

Last Modified:

11 May 2016 15:47

Publisher DOI:

10.1002/ajh.23851

PubMed ID:

25219856

BORIS DOI:

10.7892/boris.78696

URI:

https://boris.unibe.ch/id/eprint/78696

Actions (login required)

Edit item Edit item
Provide Feedback